CCP
MJN

Clough Capital Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Clough Capital Partners’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-226,400
Closed -$17.9M – 229
2013
Q2 		$17.9M Buy
+226,400
New +$18.2M 0.6% 55

Other funds holding MJN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Clough Capital Partners's MJN Position: Q3 2013 in Review

Clough Capital Partners sold out of Mead Johnson Nutrition Company (MJN) in Q3 2013, closing a stake of 226,400 shares — an estimated $17.9M sold.

Clough Capital Partners first reported a position in MJN in Q2 2013 and held it in 1 quarter. The position peaked at $17.9M in Q2 2013. 450 funds tracked by Wall St. Rank hold MJN as of Q3 2013.

  • Clough Capital Partners reported no remaining Mead Johnson Nutrition Company position as of Q3 2013 after selling out during the quarter.
  • Clough Capital Partners sold 226,400 Mead Johnson Nutrition Company shares in Q3 2013, an estimated $17.9M.
  • Clough Capital Partners first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 1 quarter.
  • Clough Capital Partners's Mead Johnson Nutrition Company position peaked at $17.9M in Q2 2013.
  • 450 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2013.

Based on Clough Capital Partners's 13F filing for Q3 2013, filed 14 Nov 2013.